These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 3044936

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA, Wang YX, Elliott M, Latif M, Chambers JT, Chambers SK, Schwartz PE.
    Cancer Res; 1988 Mar 01; 48(5):1356-60. PubMed ID: 3342414
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report.
    Cole LA, Tanaka A, Kim GS, Park SY, Koh MW, Schwartz PE, Chambers JT, Nam JH.
    Gynecol Oncol; 1996 Feb 01; 60(2):264-70. PubMed ID: 8631549
    [Abstract] [Full Text] [Related]

  • 7. Urinary gonadotropin fragment, a new tumor marker. II. Differentiating a benign from a malignant pelvic mass.
    Cole LA, Nam JH, Chambers JT, Schwartz PE.
    Gynecol Oncol; 1990 Mar 01; 36(3):391-4. PubMed ID: 2318450
    [Abstract] [Full Text] [Related]

  • 8. Urinary gonadotropin fragment, a new tumor marker. III. Use in cervical and vulvar cancers.
    Nam JH, Chang KC, Chambers JT, Schwartz PE, Cole LA.
    Gynecol Oncol; 1990 Jul 01; 38(1):66-70. PubMed ID: 2354828
    [Abstract] [Full Text] [Related]

  • 9. Urinary gonadotropin fragment, a new tumor marker. IV. Use in endometrial cancers and uterine mixed mullerian tumors.
    Nam JH, Chambers JT, Schwartz PE, Cole LA.
    Gynecol Oncol; 1990 Dec 01; 39(3):352-7. PubMed ID: 2175287
    [Abstract] [Full Text] [Related]

  • 10. Urinary chorionic gonadotropin subunits and beta-core in nonpregnant women. A study of benign and malignant gynecologic disorders.
    Neven P, Iles RK, Lee CL, Hudson CN, Shepherd JH, Chard T.
    Cancer; 1993 Jun 15; 71(12):4124-30. PubMed ID: 7685240
    [Abstract] [Full Text] [Related]

  • 11. Urinary gonadotropin peptide (UGP) as a marker of gynecologic malignancies.
    Walker R, Crebbin V, Stern J, Scudder S, Schwartz P.
    Anticancer Res; 1994 Jun 15; 14(5A):1703-9. PubMed ID: 7847804
    [Abstract] [Full Text] [Related]

  • 12. Improved methods for detecting beta-core in normal and cancer patient urines.
    Tanaka A, Cole LA.
    Clin Chem; 1994 Dec 15; 40(12):2317-8. PubMed ID: 7988019
    [No Abstract] [Full Text] [Related]

  • 13. Combination assay of urinary beta-core fragment of human chorionic gonadotropin with serum tumor markers in gynecologic cancers.
    Kinugasa M, Nishimura R, Koizumi T, Morisue K, Higashida T, Natazuka T, Nakagawa T, Isobe T, Baba S, Hasegawa K.
    Jpn J Cancer Res; 1995 Aug 15; 86(8):783-9. PubMed ID: 7559103
    [Abstract] [Full Text] [Related]

  • 14. Urinary gonadotropin fragment measurements in patients with lung and esophageal disease.
    D'Agostino RS, Cole LA, Ponn RB, Stern H, Schwartz PE.
    J Surg Oncol; 1992 Mar 15; 49(3):147-50. PubMed ID: 1548888
    [Abstract] [Full Text] [Related]

  • 15. UGP--a tumor marker of gynecologic and breast malignancies? Specificity and sensitivity in pretherapeutic patients and the influence of hormonal substitution on the expression of UGP.
    Schwarz-Roeger U, Petzoldt B, Waldschmidt R, Walker RP, Bauknecht T, Kiechle M.
    Anticancer Res; 1997 Mar 15; 17(4B):3041-5. PubMed ID: 9329597
    [Abstract] [Full Text] [Related]

  • 16. [Urinary gonadotropin fragment measurement in the monitoring of trophoblastic disease].
    Fu CY, Cole LA, Kardana A.
    Zhonghua Fu Chan Ke Za Zhi; 1994 Aug 15; 29(8):475-7, 510-1. PubMed ID: 7835119
    [Abstract] [Full Text] [Related]

  • 17. Urinary gonadotropin peptide (UGP) and serum CA 125 in gynaecologic practice, a clinical prospective study.
    Schutter EM, Mijatovic V, Kok A, Van Kamp GJ, Verstraeten R, Verheijen RH.
    Anticancer Res; 1999 Aug 15; 19(6C):5551-7. PubMed ID: 10697615
    [Abstract] [Full Text] [Related]

  • 18. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
    Yoshimura M, Nishimura R, Murotani A, Miyamoto Y, Nakagawa T, Hasegawa K, Koizumi T, Shii K, Baba S, Tsubota N.
    Cancer; 1994 Jun 01; 73(11):2745-52. PubMed ID: 7514953
    [Abstract] [Full Text] [Related]

  • 19. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
    Badgwell D, Lu Z, Cole L, Fritsche H, Atkinson EN, Somers E, Allard J, Moore RG, Lu KH, Bast RC.
    Gynecol Oncol; 2007 Sep 01; 106(3):490-7. PubMed ID: 17532030
    [Abstract] [Full Text] [Related]

  • 20. The purification and development of a radioimmunoassay for beta-core fragment of human chorionic gonadotrophin in urine: application as a marker of gynaecological cancer in premenopausal and postmenopausal women.
    Lee CL, Iles RK, Shepherd JH, Hudson CN, Chard T.
    J Endocrinol; 1991 Sep 01; 130(3):481-9. PubMed ID: 1719119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.